¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Continuous Performance Test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • radiation sensitivity test
    ¹æ»ç¼±¹Î°¨µµ°Ë»ç
  • radioallergosorbent test
    ¹æ»ç¼±¾Ë·¹¸£±âÈíÂø°Ë»ç
  • radioimmuosorbent test
    ¹æ»ç¼±¸é¿ªÈíÂø°Ë»ç
  • radioisotope diagnostic test
    ¹æ»ç¼ºµ¿À§¿ø¼ÒÁø´Ü°Ë»ç
  • reagin test
    ¸®¾Æ±ä°Ë»ç
  • recalcification test
    Ä®½·Àç÷°¡°Ë»ç
  • red blood cell survival test
    ÀûÇ÷±¸¼ö¸í°Ë»ç
  • reduction test
    ȯ¿ø½ÃÇè
  • reference test
    ±âÁذ˻ç¹ý
  • reflex righting test
    Á÷¸³¹Ý»ç°Ë»ç
  • renal function test
    ÄáÆÏ±â´É°Ë»ç, ½ÅÀå±â´É°Ë»ç
  • resorption skin test
    Èí¼öÇǺΰ˻ç
  • respiratory function test
    È£Èí±â´É°Ë»ç
  • right-wrong test
    ¿Ç°í±×¸§°Ë»ç
  • righting function test
    ¹Ù·Î¼­±â±â´É°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • hemagglutination inhibition test
    (Àû)Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý ÀúÁö½ÃÇè
  • hemagglutination inhibition test =HIT
    (Àû)Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè.
  • hemagglutination test
    (Àû)Ç÷±¸ÀÀÁý½ÃÇè
  • hemagglutination test
    Ç÷±¸ÀÀÁý¹ý
  • hemagglutination test
    Ç÷±¸ÀÀÁý °Ë»ç
  • hemagglutination test
    (Àû)Ç÷±¸ÀÀÁý½ÃÇè.
  • hemagglutination-inhibition (HI) test
    Ç÷±¸ÀÀÁý ÀúÁö½ÃÇè
  • hematoporphyrin test
    Ç츶ÅäÆ÷¸£ÇǸ°½ÃÇè.
  • hemin test
    Çì¹Î°Ë»ç(¡­ËþÞÛ).
  • hemoccult test
    ÀáÇ÷½ÃÇè
  • hemoglobin test
    Çì¸ð±Û·Îºó½ÃÇè.
  • hemoglobin test
    Çì¸ð±Û·Îºó½ÃÇè
  • hemolytic plaque test
    ¿ëÇ÷ÇöóÅ©Å×½ºÆ®.
  • hemosiderin test
    Çì¸ð½Ãµ¥¸°Å×½ºÆ®, Ç÷ö¼Ò½ÃÇè(úìôÑáÈãËúÐ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • cytotoxicity test
    ¼¼Æ÷µ¶¼º½ÃÇè(á¬øàÔ¸àõ ãËúÐ).
  • cytotoxicity test
    ¼¼Æ÷µ¶¼º½ÃÇè
  • dark room test
    ¾Ï½Ç°Ë»ç
  • delayed feedback test
    Áö¿¬Àç»ý°Ë»ç
  • delayed side tone test
    ¿Ï¼Ó¾îÀ½ ûÃë°Ë»ç¹ý
  • denervation hypersensitivity test
    bethanecholÅ»½Å°æ°ú¹Î ¹ÝÀÀ°Ë»ç
  • deoxyuridine suppression test
    µ¥¿Á½Ã¿ì¸®µò¾ïÁ¦½ÃÇè
  • depressor test
    °¨¾Ð½ÃÇè(¡­ãËúÐ).
  • dermatophyte test medium
    ÇǺλç»ó±Õ½ÃÇè¹èÁö
  • dermographic test
    ÇǺΠ¹¦±â(ù«Ý± ÙÚÑÀ) °Ë»ç(ËþÞÛ)
  • desaturated 15 hue test
    Àúäµµ15»ö»ó°Ë»ç
  • developing test
    Àü°³½ÃÇè(î÷ËÒãËúÐ).
  • developmental test of visual motor integration
    ½Ã°¢¿îµ¿ÅëÇÕ(ãÊÊÆê¡ÔÑ÷Öùê)¹ß´Þ°Ë»ç(Û¡Ó¹ËþÞÛ)
  • deviation test
    ÆíÀǰ˻ç
  • dexamethasone suppression test
    µ¦»ç¸ÞŸÁ¸¾ïÁ¦½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
CSII continuous subcutaneous insulin infusion
CSIIP continuous subcutaneous insulin infusion pump
CSUF continuous slow ultrafiltration
CTN calcitonin; clinical trials notification; computer tomography number; continuous noise
CVVH continuous veno-venous hemofiltration
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
AVLT Auditory Verbal Learning Test
BTO Balloon test occlusion
BDT Basophil Degranulation Test
BVRT Benton Visual Retention Test
BNT Boston Naming Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • isometric stress test
    µîô¼º ½ºÆ®·¹½º °Ë»ç
  • isopropanol stability test
    À̼ÒÇÁ·ÎÆÄ³î ¾ÈÁ¤¼º °Ë»ç
  • Jacobsthal's test
    ¾ßÄß½ºÅ» ¸Åµ¶ Ç÷û ¹ÝÀÀ
  • Jaeger test
    ¿¹°Å ½ÃÇè
    °¡º±°Ô ¼Õ»ó½ÃŲ ºÎÀ§¿¡ ½Ã¾àÀ» ¹ß¶ó¼­ ÇǺÎÀÇ ¾Ë·¹¸£±â¸¦ ½ÃÇèÇÏ´Â ¹æ¹ý.
  • Jaeger's test type
    ¿¹°Å ¹®ÀÚ
    ½Ã·Â °Ë»ç¿¡ »ç¿ëµÇ´Â ´ë¼ÒÀÇ ¹®ÀÚ¸¦ ´Ã¾î³õÀº Ç¥.
  • Jaffe's test
    ¾ßÆä ½ÃÇè
    ÀεðÄ­ °ËÃâ¹ý.
  • Kahns test
    Ä­ ¸Åµ¶ Ç÷û °Ë»ç
    ¸Åµ¶ Ç÷ûÀÇ Ä§°­ ¹ÝÀÀÀ¸·Î, ºñµ¿È­µÈ ÇǰËÇ÷û 3cc·Î Èñ¼®ÇÑ Ç׿ø 0.05cc¸¦ °¡ÇØ, ÇÏ·ç ¹ãÀ» 37µµ·Î À¯ÁöÇÏ¿© ħÀüÀÌ ³ªÅ¸³ª¸é ¾ç¼º.
  • Kajdi's test
    Ä«À̵ð ½ÃÇè
    ±«Ç÷º´ Áø´Ü¿¡ ÀÌ¿ëµÇ´Â ½ÃÇèÀ¸·Î, ¾Æ½ºÄÚ¸£ºó»ê 200mgÀ» ±ÙÀ°ÁÖ»çÇϰí, 4½Ã°£ ÈÄ¿¡ Ç÷ÁßÀÇ ¾Æ½ºÄÚ¸£ºó»ê·®ÀÌ 0.2mg% ÀÌÇÏÀ̸é, ºñŸ¹Î C°¡ Æ÷È­¿¡ À̸£Áö ¾Ê¾Ò´Ù°í ÆÇÁ¤ÇÑ´Ù.
  • Kamnitzer's test
    °¨´Öó ½ÃÇè
    ÀӺο¡°Ô Ç÷θ®Áø 2.5mgÀ» Åõ¿©ÇÏ¸é ´ç´¢°¡ ¹ß»ýÇÏ´Â ¹ÝÀÀÀ» ÀÌ¿ëÇÑ ÀӽнÃÇè.
  • Kasanin-Vigotsky's test
    Ä«»ç´Ñ-ºñ°íÃ÷Ű ½ÃÇè
    ´ë³úÀÇ ±âÁú¼º Áúȯ°ú ºÐ¿­¼º »óŸ¦ ±¸º°Çϱâ À§ÇÑ ½ÃÇè.
  • Katayama's test
    īŸ¾ß¸¶ ½ÃÇè¹ý
    Ç÷¾× 5¹æ¿ï¿¡ ¹° 10¹æ¿ïÀ» °¡Çϰí, ´Ù½Ã ¿À·»Áö »öÀÇ È²È­ ¾Ï¸ð´Ï¾Æ 5¹æ¿ïÀ» °¡ÇÑ ´ÙÀ½ ÃÊ»êÀ¸·Î »ê¼ºÈ­ ÇÒ ¶§ ÀÏ»êȭź¼Ò°¡ ÀÖÀ¸¸é Àå¹Ì»ö, Á¤»ó Ç÷¾×ÀÌ¸é ¾Ï·Ï»öÀ» ³ªÅ¸³½´Ù.
  • Kathrein's test
    īƮ¶óÀÎ ½ÃÇè
    ÇÇ°Ë ´¢¿¡ 1% ¿ä¿Àµå ¾ËÄÚ¿Ã ¿ë¾×À» ÁßÃþÇϸé, ´ãÁó »ö¼Ò°¡ ÀÖÀ» ¶§´Â Á¢Ã˸鿡 ³ì»öÀÌ ³ªÅ¸³­´Ù.
  • keel knee test
    ½½Á¾ °Ë»ç
  • Kinberg's test
    Ųº£¸£Å© °Ë»ç
  • Knoop hardness test
    ´©ÇÁ °æµµ½ÃÇè
    Àç·áÀÇ °æµµ¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÇ ÇÑ °¡Áö. ¿ø¸®´Â ¾ÐÀÔ °æµµ ½ÃÇèÀÌ´Ù. ´ÉÇüÀÇ ´ë°¢¼±ÀÇ ºñ°¡ 7:11:1ÀÎ ´ÙÀ̾Ƹóµå ¾ÐÀÚ¸¦ »ç¿ëÇÏ¿© Á¤ÇÏÁßÀ» °¡ÇØ Àç·áÀÇ Ç¥¸é¿¡ ¾ÐÀÔÇÏ´Â °æµµ½ÃÇèÀÌ´Ù. ź¼º¿¡ ÀÇÇØ ȸº¹·ÂÀÌ ÀÖ´Â Àç·áÀÇ °æµµ ÃøÁ¤ÀÌ °¡´ÉÇϰí, ¶ÇÇÑ ¿¬¼ºÀÌ Å« Àç·á·ÎºÎÅÍ »ó´çÈ÷ ´Ü´ÜÇÑ Àç·á¿¡ À̸£±â±îÁö ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ¹Ç·Î, ´Ù¸¥ °ø¾÷ Àç·á¿¡ ºñÇØ ³ôÀº ź·Â¼ºÀ» °®´Â Ä¡°úÀç·áÀÇ °æµµ ÃøÁ¤ ½Ã¿¡ ³Î¸® ÀÌ¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
milk-ring test A special form of agglutination test done on the pooled milk of many cows, usually entire herds, for the detection of herds containing individuals infected with bovine brucellosis.
(05 Mar 2000)
Millon Clinical Multiaxial Inventory test A paper and pencil test, consisting of 20 clinical scales derived from 175 self-descriptive statements, and developed in 1977 for use in the assessment of psychopathology and the more enduring patterns of personality; specifically designed to correspond with some of the disorders of personality included in the Diagnostic and Statistical Manual of Mental Disorders used in diagnosis by mental health professionals.
Synonym: Millon clinical multiaxial inventory.
(05 Mar 2000)
Millon-Nasse test A test for protein, the tyrosine of which reacts with nitrite after a brief treatment with mercuric ion in acid to give a colour.
(05 Mar 2000)
Clauberg test A test for progestational activity; immature rabbits are treated with 8 daily injections of oestrogen and then given 5 daily injections of the test substance; the amount required to produce definite progestational changes in the endometrium is taken as the unit; it is equivalent to 0.75 mg of progesterone.
(05 Mar 2000)
photo-patch test A test of contact photosensitization: after application of a patch with the suspected sensitiser for 48 hours to two sites, if there is no reaction one area is exposed to a weak erythema dose of sunlight or ultraviolet light; if positive, a more severe reaction with vesiculation develops at the exposed patch area than the nonexposed skin patch site.
(05 Mar 2000)
Minnesota multiphasic personality inventory test A questionnaire type of psychological test for ages 16 and over, with 550 true-false statements coded in 4 validity and 10 personality scales which may be administered in both an individual or group format.
Synonym: Minnesota Multiphasic Personality Inventory.
(05 Mar 2000)
photostress test Measurement of visual acuity before and after exposure of the eyes to intense light.
(05 Mar 2000)
phrenic pressure test Pressure is made on the phrenic nerve on each side, above the clavicles where the nerve passes over the scalenus anticus muscle; if pain is felt and the patient inclines his head to the painful side, the problem is in the pleural space; if his head does not incline to one side, the problem is in the abdominal cavity.
(05 Mar 2000)
clomiphene test A test of pituitary gonadotropin reserve using clomiphene.
(05 Mar 2000)
phthalein test An obsolete test for renal function; after the patient has drunk a glass or two of water, 1 ml of a 0.6% solution of dye is injected hypodermically; the time between this injection and the appearance of a pink tinge in the urine as it falls into an alkaline solution is noted; the amount excreted in each of the next 2 hours is then estimated colourimetrically.
Synonym: Geraghty's test, phthalein test, red test, Rowntree and Geraghty test.
(05 Mar 2000)
mixed lymphocyte culture test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
MLC test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
CO2-withdrawal seizure test Utilization of hyperventilation to demonstrate abnormalities in the brain waves or even to precipitate a convulsion.
(05 Mar 2000)
Wada test <investigation> Unilateral internal carotid injection of amobarbital to determine the laterality of speech; injection on the dominant side causes transient aphasia or mutism; used prior to surgical treatment of epilepsy.
(05 Mar 2000)
Waldenstrom's test A test for porphyrin in the urine; 2 ml of urine are mixed with an equal amount of 2% dimethyl-p-aminobenzaldehyde in 50/100 HCl. A red colour appears if urobilinogen (Ehrlich's benzaldehyde reaction) or porphobilinogen is present.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á